General Information
Revision date
2025-05-10
Product name
Iron nanopowder, APS 40 nm, 99.9%
CAS No.
7439-89-6
1.2.2. Uses advised against
Industrial. For professional use only
Emergency telephone
91 22 2207 0099
Icons in SDS
Company Information
company name
OTTO CHEMIE PVT LTD
e-mail address of the competent person responsible for the Safety Data Sheet
info@ottokemi.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H228, H251
Hazard statements
Code
Statements
H228
Flammable solid
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Flammable solids, (Category 1) H228: Flammable solid. Self-heating substances and H251: Self-heating: may catch fire. mixtures, (Category 1)
Signal word
Danger Danger
Hazard statements
H228 Flammable solid. H251 Self-heating: may catch fire. H251 Self-heating: may catch fire.
Precautionary statements
P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P235 Keep cool. P240 Ground and bond container and receiving equipment. P241 Use explosion-proof electrical/ ventilating/ lighting equipment. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P370 + P378 In case of fire: Use dry sand, dry chemical or alcohol-resistant foam to extinguish. P235 Keep cool. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection.
Supplemental label elements
Reduced Labelling (<= 125 ml) none none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher